Insulin Human (rDNA) USP
Mysulin 30/70 (40 IU)
Insulin Human (rDNA) USP
Composition : Mysulin 30/70 injection 40 IU: Each ml suspension contains Insulin Human (rDNA) USP 100 IU
(equivalent to 3.47 mg) as 30% soluble Insulin (Regular) and 70% Isophane
Insulin.
Indications :
It is indicated as an adjunct to diet and exercise to improve glycaemic control
in adult patients with type 1 and type 2 diabetes mellitus.
Dosage : The dosage
and administration time of the insulin are different due to the individual
differences of each patient. It should be given subcutaneously approximately
15-30 minutes before a meal. The average range of total daily insulin
requirement for maintenance therapy in type 1 diabetic patients lies between
0.5 and 1.0 IU/kg/day. However, in pre-pubertal children it usually varies from
0.7 to 1 IU/kg/day. In situations of insulin resistance, e.g. during puberty or
due to obesity, the daily insulin requirement may be substantially higher.
Initial dosages for patients with diabetes are often lower, e.g., 0.3 to 0.6
IU/kg/day. Or, as directed by the registered physician.
Use in pregnancy and lactation : There are no restrictions on the treatment of diabetes with
insulin during pregnancy, as insulin does not pass the placental barrier.
Insulin treatment of the nursing mother presents no risk to the baby.
Packing : Mysulin 30/70 injection 40IU: Each box contains 10ml glass vial.